A pooled analysis of 3,307 patients ( age 68.0 0.2 years ; 31.1 % female ) enrolled in AFFIRM and AF-CHF trials was conducted to assess the effect of rhythm control with amiodarone on cardiovascular outcomes , according to left ventricular systolic function .